Michael Weinstein

Why FTC Solar Is Trading Higher Today

Why Credit Suisse Is Turning Bullish On Sunrun

Credit Suisse Upgrades Dominion Energy On Valuation

Why Credit Suisse Is Turning Bullish On Sunrun

Credit Suisse Upgrades Dominion Energy On Valuation

2 First Solar Analysts Take Opposite Sides Of Trade Before Q3 Report

Sell-Side Debates First Solar's Costs, Gross Margins

2 First Solar Analysts Take Opposite Sides Of Trade Before Q3 Report

Sell-Side Debates First Solar's Costs, Gross Margins

Credit Suisse Upgrades SunPower After Solar Tariff Exemption

Credit Suisse Doubles Down On Bearish Stance Before First Solar's Q1 Print: 'Major Catalysts Are Behind Us'

Michael Weinstein Recent News

First Solar And Sunrun: A Renewable Energy Pair Trade From Credit Suisse

An Analyst's Black Hills Corp. Outlook Dims On These Twin Risks

JPMorgan Diagnoses The MedTech Space: Stock Picks And Pans

Credit Suisse: NextEra Energy A 'Premier Solar And Wind Play'

JPMorgan: Buy The Boston Scientific Dip

JPMorgan Downgrades ConforMIS After Its Sales Outlook Dropped $5 Million

JPMorgan Doesn't See A Competing Bid For St. Jude Medical, Downgrades To Neutral

J.P. Morgan Thinks Nervo Is About To Take Off, Sees Major Revenues Coming

JPMorgan Cut Its Johnson & Johnson Forecast Before Earnings, But Why?

J.P. Morgan: Johnson & Johnson's Drug Segment May Beat Q2 Street Views

UPDATE: J.P. Morgan Reiterates on Medtronic Following Solid 2Q Results

UPDATE: J.P. Morgan Downgrades Edwards Lifesciences Corp. as Street Estimates Are Too High

UPDATE: J.P. Morgan Upgrades Tornier NV on Multiple Positive Factors

J.P. Morgan Reiterates Overweight Rating on HeartWare International Following CAP Approval

UPDATE: JP Morgan Raises PT on Boston Scientific on Recent FX Movements and 1Q Result

PODD Reports Strong Q4 Results, Issues Achievable Guidance

MDT To Face Increased Competition In Kyphoplasty Market

EVVV Ready For Robust Performance In 2010